Article | 2026 Clinical Trials at the Summit
FDA Veteran Shares Insights on Trial Design and Endpoints
Former FDA ophthalmology leader Wiley A. Chambers, MD, discusses pivotal studies, safety databases, and regulatory expectations for retinal therapies.







